NR4A1 and breast carcinoma: Despite not finding these three markers to be independently prognostic of BCSS as evinced by our multivariable analysis, digital microscopy-based assessment of these and others may yet find utility in particular subgroups of breast cancer patients, for example in lymph node-negative, hormone receptor-positive patients, which have generally better prognoses.